Pharmacokinetics and Pharmacodynamics of Apixaban in End-stage Renal Disease Patients on Hemodialysis
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Apixaban (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- 29 Aug 2016 Status changed from active, no longer recruiting to completed.
- 04 Jul 2016 Planned End Date changed from 1 Jul 2016 to 1 Nov 2016.
- 04 Jul 2016 Status changed from recruiting to active, no longer recruiting.